iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/18786300/
Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Nov-Dec;22(6):549-59.
doi: 10.2500/ajr.2008.22.3228. Epub 2008 Sep 10.

Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis

Affiliations
Review

Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis

Robert C Kern et al. Am J Rhinol. 2008 Nov-Dec.

Abstract

Background: Chronic rhinosinusitis (CRS) has been defined as persistent symptomatic inflammation of the nasal and sinus mucosa resulting from the interaction of multiple host and environmental factors. Recent studies have implicated Alternaria fungi or toxigenic Staphylococcus aureus as critical agents in CRS pathogenesis. The emphasis on environmental agents in CRS etiology has focused interest toward elimination of those agents as the prime mechanism of therapy. This viewpoint is in marked contrast to the current perspective on some other chronic inflammatory epithelial disorders that afflict the skin, lungs, and gut, wherein host factors are believed to predispose to disease expression in the presence of ubiquitous environmental agents.

Methods: The current review evaluates CRS etiology from this perspective and considers that CRS develops, in part, as an outcome of a dysfunctional host response. Specifically, evidence from our laboratory and others will be reviewed indicating that CRS is associated with a failure of the mechanical and immunologic barriers across the nasal mucosa. The hypothesis would further propose that genetic and epigenetic variation predisposes susceptible individuals to barrier failure in the presence of environmental stress leading to CRS.

Results: From this unifying perspective, bacteria and fungi are seen as disease modifiers rather than primary etiologic agents.

Conclusion: The goal is to place concepts of CRS pathophysiology in a framework consistent with a current understanding of chronic inflammation in general and epithelial disease in particular.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The superantigen hypothesis proposes that Staphylococcus aureus, perhaps protected by biofilms or sequestered within epithelial cells, secretes toxins that result in a generalized stimulation of T cells with cytokine release as well as a local polyclonal IgE response. (Illustration by William E. Walsh, MD, CMI, 2008 William Walsh; used with permission.)
Figure 2
Figure 2
Epithelial defense in the nose first consists of mechanical barriers including mucociliary flow and tight junctions between respiratory epithelial cells that limit stimulation of pattern recognition receptors (PRRs) through diminished exposure and access. PRRs recognize pathogen-associated molecular patterns (PAMPs), which are conserved molecular patterns common among pathogens; recognition of PAMPs by PRRs serves as a “danger” signal to the host immune system. PRRs also identify cellular “damage” through detection of debris from necrotic cells and the combined recognition of danger and damage signals sets in motion a response consisting of endogenous antimicrobial, antiviral, and antiproteinase products designed to aid pathogen clearance. PRR activation also triggers the release of chemokines and cytokines mediating the inflammatory response that attracts innate cellular defenses such as neutrophils. If sufficiently strong, PRR stimulation also sets in motion and ultimately determines the nature of the acquired immune response. Although not considered host defense molecules, PAR receptors (not depicted) are also present on many of the cell types present in the nasal mucosa. (Illustration by William E. Walsh, MD, CMI, 2008 William Walsh; used with permission.)
Figure 3
Figure 3
Expression of the S100 family of genes, which participate in epithelial repair and defense, is decreased in chronic rhinosinusitis (CRS). This suggests that CRS is associated with diminished innate defenses and a diminished capacity for epithelial repair after damage (i.e., viral injury). SPINK5, a secreted polyvalent antiprotease, is reduced in CRS with nasal polyps (CRSwNP) patients. SPINK5 protects epithelia from the attack of endogenous and exogenous proteases suggesting that CRSwNP may be associated with a more fragile mechanical barrier. (Illustration by William E. Walsh, MD, CMI, 2008 William Walsh; used with permission.)
Figure 4
Figure 4
IL-6 action frees helper and effector T cells from the suppressive effects of IL-10 secreted by Treg cells. High levels of IL-6 protein and its soluble receptor in CRS with nasal polyps suggest the hypothesis that local increases in IL-6 activity may dampen local immunosuppression fostering polyp formation. (Illustration by William E. Walsh, MD, CMI, 2008 William Walsh; used with permission.)
Figure 5
Figure 5
Heterogeneity of chronic rhinosinusitis (CRS). According to this model, variations in the expression of genes that govern critical host epithelial pathways may increase the susceptibility to CRS. Environmental factors, rather than discrete etiologic agents, can be seen as disease modifiers that skew the clinical presentation in an individual patient. Fungi may accentuate both T-helper type 1 (TH1) and TH2 cytokine expression. Chronic inflammatory disorders occur at other sites of interface with the outside world, including the skin, gut, and lungs. (Illustration by William E. Walsh, MD, CMI, 2008 William Walsh; used with permission.)

Similar articles

Cited by

References

    1. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003;129(suppl 3):S1–S32. - PubMed
    1. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg. 2004;131(suppl 6):S1–S62. - PMC - PubMed
    1. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61:1280–1289. - PubMed
    1. Bhattacharyya N. Symptom outcomes after endoscopic sinus surgery for chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg. 2004;130:329–333. - PubMed
    1. Lund VJ. Surgical outcomes in chronic rhinosinusitis and nasal polyposis. Rhinology. 2006;44:97. - PubMed